STOCK TITAN

PMGC Holdings Confirms Compliance with Nasdaq’s New $5 Million Market Value of Listed Securities Requirement

(Neutral)
Tags

PMGC Holdings (Nasdaq: ELAB) confirmed that, as of July 29, 2026, it complies with Nasdaq’s new $5 million Market Value of Listed Securities (MVLS) continued-listing requirement. Based on its 8,095,835 issued and outstanding common shares and the applicable market price on that date, PMGC’s MVLS exceeds the new threshold.

The company is working with third-party market-data providers to correct inaccurate information that understates its current share count and market capitalization. PMGC noted that under the new Nasdaq rule, an MVLS below the minimum for 30 consecutive business days may trigger trading suspension and delisting proceedings without a cure period, and cautioned that future compliance is not assured because MVLS depends on trading price.

According to PMGC, for the quarter ended March 31, 2026, it reported total assets of approximately $26.0 million (up about 102% from $12.87 million at December 31, 2025 and about 193% year over year), shareholders’ equity of roughly $12.6 million, and cash and cash equivalents of about $14.4 million. Quarterly revenue was approximately $682,000, exceeding full-year 2025 revenue. These figures exclude the acquisition of A&B Aerospace, which closed on May 12, 2026. PMGC expects to report results for the quarter ended June 30, 2026 in August 2026.

Loading...
Loading translation...

Positive

  • MVLS exceeds Nasdaq $5M minimum as of July 29, 2026
  • 8,095,835 common shares issued and outstanding as of July 29, 2026
  • Total assets ~$26.0M, up ~102% vs. Dec 31, 2025 and ~193% YoY
  • Shareholders’ equity ~$12.6M as of March 31, 2026
  • Cash and cash equivalents ~$14.4M as of March 31, 2026
  • Q1 2026 revenue ~$682,000, exceeding full-year 2025 revenue
  • A&B Aerospace acquisition closed on May 12, 2026 (post-Q1 results)

Negative

  • New Nasdaq MVLS rule allows no cure period after 30 consecutive days below minimum
  • Company warns no assurance of future MVLS compliance due to share-price dependence
  • Inaccurate third-party data currently understates share count and market capitalization

News Explained

The supplied figures place PMGC’s $14,354,374 of cash and equivalents at 433.6 days of the first quarter’s $2,979,595 operating cash use, a historical liquidity comparison rather than a commitment of future funding.

Sources and calculations
  • Cash and equivalents vs quarterly operating cash outflow, in days of cash use $14,354,374 / ($2,979,595 / 90) = [object Object]

News Market Reaction – ELAB

-6.96%
7 alerts
-6.96% Session close to close
+2.7% Peak Tracked
-4.7% Trough Tracked
$4.54M Market Cap
0.1x Rel. Volume

In the Jul 29 session, ELAB declined 6.96%, reflecting a notable negative market reaction. Argus tracked a peak move of +2.7% during that session. Argus tracked a trough of -4.7% from its starting point during tracking. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -7.0% in the session following this news. The -2.8% reaction recorded for news_id 10...
Analysis

The stock moved -7.0% in the session following this news. The -2.8% reaction recorded for news_id 1072283 shows a prior positive corporate announcement followed by a negative response. This filing similarly included future compliance risk, while moderate short positioning remained a sourced volatility factor.

Key Figures

Shares outstanding: 8,095,835 shares MVLS deficiency period: 30 consecutive business days Total assets: $26.0 million +5 more
8 metrics
Shares outstanding 8,095,835 shares As of July 29, 2026
MVLS deficiency period 30 consecutive business days Period below Nasdaq's minimum before potential suspension and delisting proceedings
Total assets $26.0 million Three months ended March 31, 2026
Year-over-year asset growth 193% Three months ended March 31, 2026
Shareholders' equity $12.6 million As reported for the three months ended March 31, 2026
Cash and cash equivalents $14.4 million As reported for the three months ended March 31, 2026
Quarterly revenue $682,000 Quarter ended March 31, 2026; exceeded full-year 2025 revenue
Quarterly asset growth 102% Increase from December 31, 2025 to March 31, 2026

Historical Context

5 past events · Latest: Jul 13 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jul 13 Exclusive license agreement Positive -2.7% Exclusive worldwide patent license with royalties and multi-year development plan
Jul 10 Manufacturing characterization Positive +5.7% Planned FACS characterization program assessed EL-22 manufacturing comparability and product identity
Jul 06 Portfolio company merger Positive +13.6% AGA Precision Systems merged into A&B Aerospace as surviving entity
Jul 01 Phase III clinical results Positive +5.8% Four AI-selected molecules increased ANT1 expression in human skeletal muscle cells
Jun 18 Patent applications Positive -2.8% Two patent applications targeted muscle preservation alongside obesity therapies and GLP-1 treatments

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Three of the five recent news events had positive 24-hour price reactions, while two had negative reactions.

Key Terms

market value of listed securities, form 10-q, trading suspension, delisting proceedings
4 terms
market value of listed securities regulatory
"Nasdaq’s newly approved Market Value of Listed Securities (“MVLS”) continued-listing requirement"
The market value of listed securities is the total worth of stocks, bonds and other tradable instruments quoted on an exchange, measured using the prices investors are willing to pay right now. It’s calculated by multiplying each security’s current market price by the number of units outstanding and adding those amounts together, like totaling the value of every item in a store at today’s prices. Investors watch this because it shows the size, liquidity and overall health of the market or a company’s publicly traded portion, and it influences index weights, fund allocations and perceived risk.
form 10-q regulatory
"As reported in the Company’s Quarterly Report on Form 10-Q"
A Form 10-Q is a detailed report that publicly traded companies are required to file with regulators three times a year, providing an update on their financial health and business activities. It is important for investors because it offers timely insights into a company's performance, helping them make informed decisions about buying or selling stocks. Think of it as a regular check-up report that shows how well a company is doing.
trading suspension regulatory
"may become subject to trading suspension and delisting proceedings without a cure period"
A trading suspension is a temporary halt on buying and selling a company's stock imposed by an exchange or regulator while a specific issue is resolved or more information is provided. It matters to investors because it freezes the market value and prevents trades—like pausing a game until the referee clears a disputed play—so investors cannot adjust positions and may face sudden price moves or uncertainty when trading resumes.
delisting proceedings regulatory
"subject to trading suspension and delisting proceedings without a cure period"
Delisting proceedings are the formal steps taken to remove a company’s shares from a stock exchange, either because the company chose to leave or failed to meet rules like minimum share price, reporting or solvency requirements. For investors this matters because removal usually cuts trading access and liquidity, can sharply lower the share price, and makes it harder to buy, sell or get transparent information — similar to a product being pulled off supermarket shelves.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Company Reports 8,095,835 Shares of Common Stock Issued and Outstanding as of July 29, 2026, and Moves to Correct Third-Party Market Data That Understates Its Current Share Count and Market Capitalization

NEWPORT BEACH, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (Nasdaq: ELAB) (“PMGC” or the “Company”), a diversified public holding company, today confirmed that it is in compliance with Nasdaq’s newly approved Market Value of Listed Securities (“MVLS”) continued-listing requirement and announced that it is working with third-party market-data providers to correct inaccurate share count and market capitalization data currently displayed for the Company.

The Company is aware that certain third-party market-data websites are displaying an incorrect number of PMGC’s issued and outstanding shares.

As of July 29, 2026, PMGC has 8,095,835 shares of common stock issued and outstanding. The Company plans to work with the applicable market-data providers to update their records to accurately reflect PMGC’s current issued and outstanding share count and capital structure.

The Securities and Exchange Commission recently approved Nasdaq's new rule requiring companies listed on the Nasdaq Capital Market, Nasdaq Global Market and Nasdaq Global Select Market to maintain a minimum MVLS. Under the new rule, which took effect immediately upon approval, a company whose MVLS remains below the minimum for 30 consecutive business days may become subject to trading suspension and delisting proceedings without a cure period. Based on PMGC’s issued and outstanding common shares and the applicable market price as of July 29, 2026, the Company’s MVLS exceeds the new requirement.

PMGC intends to continue monitoring its MVLS and working to maintain compliance with the new requirement and all other applicable Nasdaq continued-listing standards. Because the Company’s MVLS is affected by changes in its common-stock trading price, there can be no assurance that PMGC will continue to satisfy the requirement in the future.

Most Recently Reported Financial Position

As reported in the Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2026, PMGC had total assets of approximately $26.0 million, up approximately 102% from approximately $12.87 million at December 31, 2025 and up approximately 193% year over year; shareholders’ equity of approximately $12.6 million; and cash and cash equivalents of approximately $14.4 million. Revenue for the quarter was approximately $682,000, exceeding the Company’s full-year 2025 revenue. These figures do not reflect the acquisition of A&B Aerospace, Inc., which closed on May 12, 2026. The Company expects to report its results for the quarter ended June 30, 2026 in August 2026.

About PMGC Holdings Inc.

PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. We are committed to exploring opportunities in multiple sectors to maximize growth and value. For more information, please visit https://www.pmgcholdings.com.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as “believes,” “expects,” “plans,” “potential,” “would” and “future” or similar expressions such as “look forward” are intended to identify forward-looking statements. Forward-looking statements are made as of the date of this press release and are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, activities of regulators and future regulations and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results. Therefore, you should not rely on any of these forward-looking statements. These and other risks are described more fully in PMGC’s filings with the United States Securities and Exchange Commission (“SEC”), including the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 30, 2026, and its other documents subsequently filed with or furnished to the SEC. Investors and security holders are urged to read these documents free of charge on the SEC’s web site at www.sec.gov. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except to the extent required by law, the Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Investor Relations Contact

IR@pmgcholdings.com


FAQ

Is PMGC Holdings (Nasdaq: ELAB) currently in compliance with Nasdaq’s $5 million MVLS rule?

Yes. PMGC Holdings reports that its MVLS exceeds Nasdaq’s new $5 million requirement as of July 29, 2026. According to PMGC, this is based on 8,095,835 issued and outstanding common shares and the applicable market price on that date.

How many PMGC Holdings (ELAB) shares are issued and outstanding as of July 29, 2026?

PMGC Holdings reports 8,095,835 shares of common stock issued and outstanding as of July 29, 2026. According to PMGC, it is working with third-party market-data providers to correct lower figures currently shown on some financial websites.

What are the key Q1 2026 financial results for PMGC Holdings (Nasdaq: ELAB)?

For Q1 2026, PMGC reported total assets of about $26.0 million and revenue of roughly $682,000. According to PMGC, assets rose about 102% versus December 31, 2025, 193% year over year, with shareholders’ equity near $12.6 million and cash about $14.4 million.

How does Nasdaq’s new MVLS rule affect PMGC Holdings (ELAB) listing status?

Nasdaq’s new MVLS rule requires PMGC to maintain at least $5 million in market value of listed securities. According to PMGC, remaining below the minimum for 30 consecutive business days may subject the company to trading suspension and delisting proceedings without a cure period.

Why is PMGC Holdings (Nasdaq: ELAB) correcting third-party share count and market cap data?

PMGC says some market-data sites show an incorrect, lower share count and market capitalization. According to PMGC, it plans to work with these providers so their records reflect the accurate 8,095,835 shares and the company’s current capital structure.

Does the A&B Aerospace acquisition impact PMGC Holdings (ELAB) reported Q1 2026 figures?

No. PMGC’s Q1 2026 financial figures do not include the A&B Aerospace acquisition. According to PMGC, the acquisition closed on May 12, 2026, after the March 31, 2026 quarter-end, so its impact will appear in later reporting periods.

What risks does PMGC Holdings (Nasdaq: ELAB) highlight regarding future MVLS compliance?

PMGC cautions that there is no assurance it will always meet Nasdaq’s MVLS requirement. According to PMGC, its MVLS depends on changes in its common stock trading price, which could affect continued compliance over time.